Walleye Capital LLC Global Blood Therapeutics, Inc. Call Options Transaction History

Walleye Capital LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2020 May 15, 2020	SELL	$41.72 - $87.2 $734,272 - $1.53 Million	-17,600 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $3.5 Million - $6.26 Million	-76,500 Reduced 81.3%	17,600 $1.4 Million
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $3.39 Million - $4.33 Million	74,700 Added 385.05%	94,100 $4.57 Million
Q2 2019 Aug 14, 2019	SELL	$52.6 - $63.29 $468,140 - $563,281	-8,900 Reduced 31.45%	19,400 $1.02 Million
Q1 2019 May 15, 2019	BUY	$39.99 - $53.48 $1.13 Million - $1.51 Million	28,300 New	28,300 $1.5 Million

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.